Evans, D G, Burghel, G J, Schlecht, H, Harkness, E F, Gandhi, A, Howell, S J, Howell, A, Forde, C, Lalloo, F, Newman, W G, Smith, M J & Woodward, E R 2023, ' Detection of pathogenic variants in breast cancer susceptibility genes in bilateral breast cancer ', Journal of Medical Genetics . https://doi.org/10.1136/jmg-2023-109196
Howell, S J, Casbard, A, Carucci, M, Ingarfield, K, Butler, R, Morgan, S, Meissner, M, Bale, C, Bezecny, P, Moon, S, Twelves, C, Venkitaraman, R, Waters, S, de Bruin, E C, Schiavon, G, Foxley, A & Jones, R H 2022, ' Fulvestrant plus capivasertib versus placebo after relapse or progression on an aromatase inhibitor in metastatic, oestrogen receptor-positive, HER2-negative breast cancer (FAKTION) : overall survival, updated progression-free survival, and expanded biomarker analysis from a randomised, phase 2 trial ', The Lancet. Oncology, vol. 23, no. 7, pp. 851-864 . https://doi.org/10.1016/S1470-2045(22)00284-4
Evans, D G, Sithambaram, S, van Veen, E M, Burghel, G J, Schlecht, H, Harkness, E, Byers, H J, Ellingford, J, Gandhi, A, Howell, S J, Howell, T, Forde, C, Lalloo, F, Newman, W, Smith, M J & Woodward, E 2022, ' Differential involvement of germline pathogenic variants in breast cancer genes between DCIS and low-grade invasive cancers ', Journal of Medical Genetics . https://doi.org/10.1136/jmg-2022-108790